Amphastar Pharmaceuticals Exceeds Q1 Earnings Expectations, Signals Strategic Growth
Amphastar Pharmaceuticals Inc. exceeded Q1 earnings expectations, reporting $170.5 million in net revenues and highlighting its strategic initiatives aimed at sustaining growth in the pharmaceutical industry.
- Amphastar Pharmaceuticals Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read